What is the market doing?
What the tape says about IOVA
Iovance Biotherapeutics, Inc. is +206% over the past year while the S&P 500 is +23%: 184 points ahead of the market.
+206%
1-year return · S&P 500 +23%
- vs 200-day average
- +126%
vs 200-day average · a clear uptrend
- RSI (14)
- 69
RSI (14) · neutral
- Below its 52-week high
- −9.8%
Below its 52-week high
Details›
- Last close2026-08-26
- $8.09
- 1 monthS&P 500 +3.7%
- +58%
- 1 yearS&P 500 +23%
- +206%
- 5 yearsS&P 500 +87%
- −64%
- vs 50-day average$5.23
- +55%
- 52-week high
- $8.97
- 52-week low
- $1.81
- Annualised volatility
- 102%
| Year | Return |
|---|---|
| 2026 (year to date) | +196% |
| 2025 | −63% |
| 2024 | −9.0% |
| 2023 | +27% |
| 2022 | −67% |
| 2021 | −59% |
| 2020 | +68% |
| 2019 | +213% |
| 2018 | +11% |
| 2017 | +15% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +5.4% |
| Feb | 10 | 6 of 10 | +18% |
| Mar | 10 | 1 of 10 | −8.4% |
| Apr | 10 | 3 of 10 | −2.9% |
| May | 10 | 4 of 10 | −7.6% |
| Jun | 10 | 5 of 10 | +14% |
| Jul | 11 | 9 of 11 | +6.4% |
| Aug | 11 | 5 of 11 | +8.1% |
| Sep | 10 | 3 of 10 | −6.8% |
| Oct | 10 | 4 of 10 | −3.6% |
| Nov | 10 | 7 of 10 | +6.5% |
| Dec | 10 | 6 of 10 | +5.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.